ReviewOrphanet journal of rare diseases2020

Small molecule drug development for rare genodermatoses - evaluation of the current status in epidermolysis bullosa.

Verena Wally et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.